Vestmark Advisory Solutions Inc. Buys Shares of 63,270 Teladoc Health, Inc. (NYSE:TDOC)

Vestmark Advisory Solutions Inc. bought a new stake in Teladoc Health, Inc. (NYSE:TDOCFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 63,270 shares of the health services provider’s stock, valued at approximately $575,000.

Several other large investors also recently bought and sold shares of the company. Point72 Asset Management L.P. lifted its position in shares of Teladoc Health by 57.8% in the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after acquiring an additional 3,063,172 shares in the last quarter. Maple Rock Capital Partners Inc. purchased a new stake in shares of Teladoc Health in the third quarter valued at $11,291,000. Invenomic Capital Management LP lifted its position in shares of Teladoc Health by 155.2% in the third quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock valued at $13,534,000 after acquiring an additional 896,552 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after acquiring an additional 424,180 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Teladoc Health by 18.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock valued at $22,213,000 after acquiring an additional 384,528 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Price Performance

TDOC stock opened at $9.16 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $15.95. The firm has a market cap of $1.59 billion, a P/E ratio of -1.59 and a beta of 1.27. The stock has a 50-day simple moving average of $10.62 and a 200-day simple moving average of $9.65.

Teladoc Health (NYSE:TDOCGet Free Report) last posted its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. On average, equities analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Piper Sandler reduced their target price on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. The Goldman Sachs Group reduced their target price on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Bank of America increased their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Finally, Royal Bank of Canada increased their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $11.26.

View Our Latest Analysis on TDOC

About Teladoc Health

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Recommended Stories

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCFree Report).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.